Desipramine is a secondary amine tricyclic antidepressant that is FDA approved for the treatment of depression. This drug has off-label use to treat bulimia nervosa, irritable bowel syndrome, neuropathic pain, overactive bladder, post-herpetic neuralgia, and ADHD. This activity reviews the current applications, pharmacology, and toxicities of desipramine and highlights the role of the interprofessional team, improving care for patients on this medication.

**Objectives:**
- Identify the FDA-approved indications for the use of desipramine.
- Review the mechanism of action of desipramine.
- Summarize key points in monitoring and managing desipramine therapy and toxicity. 
- Describe the importance of collaboration and communication among the interprofessional team to enhance care coordination for the patient receiving desipramine.